Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Safety and Effectiveness of Voyager's Access Device for Patients Undergoing Routine Hemodialysis (Access Cannulation Trial II)
This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
This clinical investigation is estimated to last approximately 48-60 months, from initial participant enrollment until all data collection is complete on the final participant. After the patient has the study device implanted, they will be observed for 6 weeks as the implant site heals. The patient will be monitored for 36 months after device implantation as they undergo routine dialysis. Subjects will exit the investigation after the last visit and no device-related adverse events have been identified or are being monitored
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Trinity Research Group
Dothan, Alabama, United States
Apex Research
Riverside, California, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Northwell Health
Hyde Park, New York, United States
MUSC Health Orangeburg
Orangeburg, South Carolina, United States
Cardiothoracic and Vascular Surgeons
Austin, Texas, United States
Baylor Scott & White
Dallas, Texas, United States
Fairlawn Surgery Center
Roanoke, Virginia, United States
Start Date
April 23, 2025
Primary Completion Date
March 25, 2027
Completion Date
March 25, 2027
Last Updated
October 29, 2025
100
ESTIMATED participants
VenaSure
DEVICE
Lead Sponsor
Voyager Biomedical
NCT07447791
NCT07179536
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06770374